CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers

CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers

Abstract Background Asymptomatic carriers of leucine-rich repeat kinase 2 (LRRK2) gene mutations constitute an ideal population for discovering prodromal biomarkers of Parkinson’s disease (PD). In this study, we aim to identify CSF candidate risk biomarkers of PD in individuals with LRRK2 mutation c...

Full description

Bibliographic Details
Main Authors: Nour K. Majbour, Jan O. Aasly, Eldbjørg Hustad, Mercy A. Thomas, Nishant N. Vaikath, Naser Elkum, Wilma D. J. van de Berg, Takahiko Tokuda, Brit Mollenhauer, Henk W. Berendse, Omar M. A. El-Agnaf
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Translational Neurodegeneration
Subjects:
Parkinson’s disease
LRRK2 mutation carriers
Alpha-synuclein oligomers
Biomarkers
Inflammatory markers
Online Access:http://link.springer.com/article/10.1186/s40035-020-00192-4

Internet

http://link.springer.com/article/10.1186/s40035-020-00192-4

Similar Items